LLY vs IDXX
By Alex · Tickerpine
Eli Lilly and Company vs IDEXX Laboratories, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | IDXX |
|---|---|---|
| Price | $1,220.28 | $570.58 |
| Market cap | $1.09T | $44.95B |
| P/E ratio | 41.0 | 41.1 |
| ROE | 102.29% | 74.21% |
| Profit margin | 33.53% | 25.03% |
| Revenue growth | 47.70% | 9.70% |
| Dividend yield | 0.57% | — |
| Beta | 0.51 | 1.54 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs IDXX in plain English
- LLY is the bigger company — about 24.2× the market cap of IDXX.
- LLY is cheaper on earnings (P/E 41.0 vs 41.1).
- LLY earns a higher return on equity (102% vs 74%).
- LLY is growing revenue faster (48% vs 10%).
- LLY pays a dividend (0.57%) while the other effectively doesn't.
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
IDXX return calculator
See what $1,000 in IDEXX Laboratories, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.